Enlivex Therapeutics

Recent executive movements at Enlivex Therapeutics

Brian Schwartz has joined the company as Director  (news posted on November 18 2020).

Create an alert
to follow the executive moves at Enlivex Therapeutics.

Most searched biographies at Enlivex Therapeutics

• Shai Novik, Executive Chairman of the Board
• Michel Habib, Director
• Abraham Havron, Director

Click on an executive to view his biography >

Latest M&A news in Biotechnology.

Kymab and Sanofi have announced they will merge (posted on Jan 11, 2021).
PerkinElmer has announced the acquisition of Oxford Immunotec (posted on Jan 8, 2021).
Syneos Health has announced the acquisition of SynteractHCR (posted on Dec 18, 2020).

Other contacts in the Biotechnology industry

• Chandra Leo - Director at Gynesonics
• Tal Zaks - Non-Executive Director at Adaptimmune Therapeutics
• Jean-Marc Roelandt - Chief Financial Officer at Biocartis

Learn more about the Biotechnology industry >

Latest news about Enlivex Therapeutics

Enlivex Therapeutics on Wikipedia, Google News & Yahoo Finance

Enlivex Therapeutics on LinkedIn, Twitter & YouTube

Enlivex Therapeutics has 1,539 competitors including Biogen (United States (USA)), Agilyx (United States (USA)) and Eurofins (France).

Contact by email its executives including Brian Schwartz

Call Enlivex Therapeutics at +972 ....

View the org chart

Register to receive your alert

Report an error